Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 2 |
2010 | 1 |
2017 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
kaleta j
(80 results)?
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12.
N Engl J Med. 2017.
PMID: 28605603
Free PMC article.
Clinical Trial.
Ticagrelor-Related Severe Dyspnoea: Mechanisms, Characteristic Features, Differential Diagnosis and Treatment.
Krakowiak A, Kuleta J, Plech I, Zarębiński M, Wojciechowska M, Wretowski D, Cudnoch-Jędrzejewska A.
Krakowiak A, et al. Among authors: kuleta j.
Clin Med Insights Case Rep. 2020 Oct 8;13:1179547620956634. doi: 10.1177/1179547620956634. eCollection 2020.
Clin Med Insights Case Rep. 2020.
PMID: 33100831
Free PMC article.
Item in Clipboard
Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial.
Ratner RE, Rosenstock J, Boka G; DRI6012 Study Investigators.
Ratner RE, et al.
Diabet Med. 2010 Sep;27(9):1024-32. doi: 10.1111/j.1464-5491.2010.03020.x.
Diabet Med. 2010.
PMID: 20722676
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy.
Pratley RE, Kipnes MS, Fleck PR, Wilson C, Mekki Q; Alogliptin Study 007 Group.
Pratley RE, et al.
Diabetes Obes Metab. 2009 Feb;11(2):167-76. doi: 10.1111/j.1463-1326.2008.01016.x.
Diabetes Obes Metab. 2009.
PMID: 19125778
Clinical Trial.
Item in Clipboard
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU).
Marre M, Shaw J, Brändle M, Bebakar WM, Kamaruddin NA, Strand J, Zdravkovic M, Le Thi TD, Colagiuri S; LEAD-1 SU study group.
Marre M, et al.
Diabet Med. 2009 Mar;26(3):268-78. doi: 10.1111/j.1464-5491.2009.02666.x.
Diabet Med. 2009.
PMID: 19317822
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite